Control of Cullin-Ring Ubiquitin Ligase Activity by Nedd8

  • Raymond J. Deshaies
  • Ethan D. Emberley
  • Anjanabha Saha
Part of the Subcellular Biochemistry book series (SCBI, volume 54)


The Cullin-RING ubiquitin ligase (CRL) family, which may number as many as 350 different enzymes, has an enormous impact on cellular regulation. CRL enzymes regulate cell biology by conjugating ubiquitin onto target proteins that are involved in a multitude of processes. In most cases this leads to degradation of the target, but in some cases CRL-dependent ubiquitination acts as a switch to activate or repress target function. The ubiquitin ligase activity of CRLs is controlled by cycles of attachment and removal of the ubiquitin-like protein Nedd8. Conjugation of Nedd8 onto the cullin subunit of CRLs promotes assembly of an intact CRL complex and switches on ubiquitin ligase activity. Conversely, removal of Nedd8 switches off ubiquitin ligase activity and initiates CRL disassembly. Continuous maintenance of CRL function in vivo requires the activities of both the Nedd8-conjugating and deconjugating enzymes, pointing to a critical role of complex dynamics in CRL function. Here, we review how the Nedd8 cycle controls CRL activity and how perturbations of this cycle can lead to disease.


Critical Role Human Physiology Arabidopsis Thaliana Target Protein Ubiquitin Ligase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67:425–479.PubMedGoogle Scholar
  2. 2.
    Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001; 70:503–533.PubMedGoogle Scholar
  3. 3.
    Thrower JS, Hoffman L, Rechsteiner M et al. Recognition of the polyubiquitin proteolytic signal. EMBO J 2000; 19:94–102.PubMedGoogle Scholar
  4. 4.
    Chau V, Tobias JW, Bachmair A et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 1989; 243:1576–1583.PubMedGoogle Scholar
  5. 5.
    Jin L, Williamson A, Banerjee S et al. Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell 2008; 133:653–665.PubMedGoogle Scholar
  6. 6.
    Grabbe C, Dikic I. Functional roles of ubiquitin-like domain and ubiquitin-binding domain containing proteins. Chem Rev 2008; submitted.Google Scholar
  7. 7.
    Dye BT, Schulman BA. Structural mechanisms underlying posttranslational modification by ubiquitin-like proteins. Annu Rev Biophys Biomol Struct 2007; 36:131–150.PubMedGoogle Scholar
  8. 8.
    Seol JH, Feldman RM, Zachariae W et al. Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34. Genes Dev 1999; 13:1614–1626.PubMedGoogle Scholar
  9. 9.
    Deshaies RJ, Joazeiro CA. RING domain E3 ubiquitin ligases. Annu Rev Biochem 2009; 78:399–434.PubMedGoogle Scholar
  10. 10.
    Willems AR, Schwab M, Tyers M. A hitchhiker’s guide to the cullin ubiquitin ligases: SCF and its kin. Biochim Biophys Acta 2004; 1695:133–170.PubMedGoogle Scholar
  11. 11.
    Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 2005; 6:9–20.PubMedGoogle Scholar
  12. 12.
    Cardozo T, Pagano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol 2004; 5:739–751.PubMedGoogle Scholar
  13. 13.
    Jin J, Cardozo T, Lovering RC et al. Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev 2004; 18:2573–2580.PubMedGoogle Scholar
  14. 14.
    Zachariae W, Shevchenko A, Andrews PD et al. Mass spectrometric analysis of the anaphase-promoting complex from yeast: identification of a subunit related to cullins. Science 1998; 279:1216–1219.PubMedGoogle Scholar
  15. 15.
    Schwob E, Bohm T, Mendenhall MD et al. The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae. Cell 1994; 79:233–244.PubMedGoogle Scholar
  16. 16.
    Skowyra D, Craig KL, Tyers M et al. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 1997; 91:209–219.PubMedGoogle Scholar
  17. 17.
    Feldman RM, Correll CC, Kaplan KB et al. A complex of Cdc4p, Skp1p and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 1997; 91:221–230.PubMedGoogle Scholar
  18. 18.
    Saha A, Deshaies RJ. Multimodal activation of ubiquitin ligase SCF by Nedd8 conjugation. Mol Cell 2008; 32:21–31.PubMedGoogle Scholar
  19. 19.
    Butz N, Ruetz S, Natt F et al. The human ubiquitin-conjugating enzyme Cdc34 controls cellular proliferation through regulation of p27Kip1 protein levels. Exp Cell Res 2005; 303:482–493.PubMedGoogle Scholar
  20. 20.
    Cohen S, Achbert-Weiner H, Ciechanover A. Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-T rCP)-dependent degradation and SCF(beta-T rCP)-independent processing. Mol Cell Biol 2004; 24:475–486.PubMedGoogle Scholar
  21. 21.
    Pierce NW, Kleiger G, Shan S et al. Millisecond kinetics of a ubiquitin ligase reveals sequential processivity. Nature 2009; 462:615–619.PubMedGoogle Scholar
  22. 22.
    Kim HT, Kim KP, Lledias F et al. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J Biol Chem 2007; 282:17375–17386.PubMedGoogle Scholar
  23. 23.
    Rodrigo-Brenni MC, Morgan DO. Sequential E2s drive polyubiquitin chain assembly on APC targets. Cell 2007; 130:127–139.PubMedGoogle Scholar
  24. 24.
    Summers MK, Pan B, Mukhyala K et al. The unique N terminus of the UbcH10 E2 enzyme controls the threshold for APC activation and enhances checkpoint regulation of the APC. Mol Cell 2008; 31:544–556.PubMedGoogle Scholar
  25. 25.
    Kleiger G, Saha A, Lewis S et al. Rapid dynamics of Cdc34-SCF assembly and disassembly enable processive polyubiquitylation of CRL substrates. Cell 2009; 139:957–968.PubMedGoogle Scholar
  26. 26.
    Kleiger G, Hao B, Mohl DA et al. The acidic tail of the CDC34 ubiquitin-conjugating enzyme functions in both binding to and catalysis with ubiquitin ligase SCFCDC4. J Biol Chem 2009; 284: 36012–36023.PubMedGoogle Scholar
  27. 27.
    Petroski MD, Deshaies RJ. Mechanism of lysine 48 linked ubiquitin chain synthesis onto proteins through the SCF/Cdc34 pathway. Cell 2005; 123:1107–1120.PubMedGoogle Scholar
  28. 28.
    Ravid T, Hochstrasser M. Degradation signal diversity in the ubiquitin-proteasome system. Nature Rev Mol Cell Biol 2008; 9:679–690.Google Scholar
  29. 29.
    Wu G, Xu G, Schulman BA et al. Structure of a beta-T rCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-T rCP1) ubiquitin ligase. Mol Cell 2003; 11:1445–1456.PubMedGoogle Scholar
  30. 30.
    Orlicky S, Tang X, Willems A et al. Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell 2003; 112:243–256.PubMedGoogle Scholar
  31. 31.
    Hao B, Zheng N, Schulman BA et al. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase. Mol Cell 2005; 20:9–19.PubMedGoogle Scholar
  32. 32.
    Hao B, Oehlmann S, Sowa ME et al. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol Cell 2007; 26:131–143.PubMedGoogle Scholar
  33. 33.
    Zheng N, Schulman BA, Song L et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 2002; 416:703–709.PubMedGoogle Scholar
  34. 34.
    Pan ZQ, Kentsis A, Dias DC et al. Nedd8 on cullin: building an expressway to protein destruction. Oncogene 2004; 23:1985–1997.PubMedGoogle Scholar
  35. 35.
    Tateishi K, Omata M, Tanaka K et al. The NED 8 system is essential for cell cycle progression and morphogenetic pathway in mice. J Cell Biol 2001; 155:571–579.PubMedGoogle Scholar
  36. 36.
    Osaka F, Saeki M, Katayama S et al. Covalent modifier NED 8 is essential for SCF ubiquitin-ligase in fission yeast. EMBO J 2000; 19:3475–3484.PubMedGoogle Scholar
  37. 37.
    Liakopoulos D, Doenges G, Matuschewski K et al. A novel protein modification pathway related to the ubiquitin system. EMBO J 1998; 17:2208–2214.PubMedGoogle Scholar
  38. 38.
    Lammer D, Mathias N, Laplaza JM et al. Modification of yeast Cdc53p by the ubiquitin-related protein rub1p affects function of the SCFCdc4 complex. Genes Dev 1998; 12:914–926.PubMedGoogle Scholar
  39. 39.
    Kamura T, Conrad MN, Yan Q et al. The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2. Genes Dev 1999; 13:2928–2933.PubMedGoogle Scholar
  40. 40.
    Huang DT, Ayrault O, Hunt HW et al. E2-RING expansion of the NED 8 cascade confers specificity to cullin modification. Mol Cell 2009; 33:483–495.PubMedGoogle Scholar
  41. 41.
    Kurz T, Ozlu N, Rudolf F et al. The conserved protein DCN-1/Dcn1p is required for cullin neddylation in C. elegans and S. cerevisiae. Nature 2005; 435:1257–1261.PubMedGoogle Scholar
  42. 42.
    Wada H, Yeh ET, Kamitani T. Identification of NED 8-conjugation site in human cullin-2. Biochem Biophys Res Commun 1999; 257:100–105.PubMedGoogle Scholar
  43. 43.
    Skaar JR, Florens L, Tsutsumi T et al. PARC and CUL7 form atypical cullin RING ligase complexes. Cancer Res 2007; 67:2006–2014.PubMedGoogle Scholar
  44. 44.
    Hori T, Osaka F, Chiba T et al. Covalent modification of all members of human cullin family proteins by NED 8. Oncogene 1999; 18:6829–6834.PubMedGoogle Scholar
  45. 45.
    Jones J, Wu K, Yang Y et al. A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. J Proteome Res 2008; 7:1274–1287.PubMedGoogle Scholar
  46. 46.
    Liu J, Furukawa M, Matsumoto T et al. NED 8 modification of CUL1 dissociates p120(CAND1), an inhibitor of CUL1-SKP1 binding and SCF ligases. Mol Cell 2002; 10:1511–1518.PubMedGoogle Scholar
  47. 47.
    Zheng J, Yang X, Harrell JM et al. CAND1 binds to unneddylated CUL1 and regulates the formation of SCF ubiquitin E3 ligase complex. Mol Cell 2002; 10:1519–1526.PubMedGoogle Scholar
  48. 48.
    Schmidt MW, McQuary PR, Wee S et al. F-box-directed CRL complex assembly and regulation by the CSN and CAND1. Mol Cell 2009; 35:586–597.PubMedGoogle Scholar
  49. 49.
    Goldenberg SJ, Cascio TC, Shumway SD et al. Structure of the Cand1-Cul1-Roc1 complex reveals regulatory mechanisms for the assembly of the multisubunit cullin-dependent ubiquitin ligases. Cell 2004; 119:517–528.PubMedGoogle Scholar
  50. 50.
    Bornstein G, Ganoth D, Hershko A. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate. Proc Natl Acad Sci USA 2006; 103:11515–11520.PubMedGoogle Scholar
  51. 51.
    Chuang HW, Zhang W, Gray WM. Arabidopsis ET A2, an apparent ortholog of the human cullin-interacting protein CAND1, is required for auxin responses mediated by the SCF(TIR1) ubiquitin ligase. Plant Cell 2004; 16:1883–1897.PubMedGoogle Scholar
  52. 52.
    Wu K, Chen A, Pan ZQ. Conjugation of Nedd8 to CUL1 enhances the ability of the ROC1-CUL1 complex to promote ubiquitin polymerization. J Biol Chem 2000; 275:32317–32324.PubMedGoogle Scholar
  53. 53.
    Read MA, Brownell JE, Gladysheva TB et al. Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha. Mol Cell Biol 2000; 20:2326–2333.PubMedGoogle Scholar
  54. 54.
    Podust VN, Brownell JE, Gladysheva TB et al. A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination. Proc Natl Acad Sci USA 2000; 97:4579–4584.PubMedGoogle Scholar
  55. 55.
    Morimoto M, Nishida T, Honda R et al. Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1). Biochem Biophys Res Commun 2000; 270:1093–1096.PubMedGoogle Scholar
  56. 56.
    Furukawa M, Zhang Y, McCarville J et al. The CUL1 C-terminal sequence and ROC1 are required for efficient nuclear accumulation, NED 8 modification and ubiquitin ligase activity of CUL1. Mol Cell Biol 2000; 20:8185–8197.PubMedGoogle Scholar
  57. 57.
    Kawakami T, Chiba T, Suzuki T et al. NED 8 recruits E2-ubiquitin to SCF E3 ligase. EMBO J 2001; 20:4003–4012.PubMedGoogle Scholar
  58. 58.
    Sakata E, Yamaguchi Y, Miyauchi Y et al. Direct interactions between NED 8 and ubiquitin E2 conjugating enzymes upregulate cullin-based E3 ligase activity. Nat Struct Mol Biol 2007; 14:167–168.PubMedGoogle Scholar
  59. 59.
    Brzovic PS, Keeffe JR, Nishikawa H et al. Binding and recognition in the assembly of an active BRCA1/ BARD1 ubiquitin-ligase complex. Proc Natl Acad Sci USA 2003; 100:5646–5651.PubMedGoogle Scholar
  60. 60.
    Duda DM, Borg LA, Scott DC et al. Structural insights into NED 8 activation of cullin-RING ligases: conformational control of conjugation. Cell 2008; 134:995–1006.PubMedGoogle Scholar
  61. 61.
    Soucy TA, Smith PG, Milhollen MA et al. An inhibitor of NED 8-activating enzyme as a new approach to treat cancer. Nature 2009; 458:732–736.PubMedGoogle Scholar
  62. 62.
    Lyapina S, Cope G, Shevchenko A et al. Promotion of NED-CUL1 conjugate cleavage by COP9 signalosome. Science 2001; 292:1382–1385.PubMedGoogle Scholar
  63. 63.
    Cope GA, Deshaies RJ. COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases. Cell 2003; 114:663–671.PubMedGoogle Scholar
  64. 64.
    Wei N, Deng XW. The COP9 signalosome. Annu Rev Cell Dev Biol 2003; 19:261–286.PubMedGoogle Scholar
  65. 65.
    Bech-Otschir D, Seeger M, Dubiel W. The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis. J Cell Sci 2002; 115:467–473.PubMedGoogle Scholar
  66. 66.
    Chamovitz DA. Revisiting the COP9 signalosome as a transcriptional regulator. EMBO Rep 2009; 10:352–358.PubMedGoogle Scholar
  67. 67.
    Bjorklund M, Taipale M, Varjosalo M et al. Identification of pathways regulating cell size and cell-cycle progression by RNAi. Nature 2006; 439:1009–1013.PubMedGoogle Scholar
  68. 68.
    Suh GS, Poeck B, Chouard T et al. Drosophila JAB1/CSN5 acts in photoreceptor cells to induce glial cells. Neuron 2002; 33:35–46.PubMedGoogle Scholar
  69. 69.
    Wei N, Serino G, Deng XW. The COP9 signalosome: more than a protease. Trends Biochem Sci 2008; 33:592–600.PubMedGoogle Scholar
  70. 70.
    Chamovitz DA, Wei N, Osterlund MT et al. The COP9 complex, a novel multisubunit nuclear regulator involved in light control of a plant developmental switch. Cell 1996; 86:115–121.PubMedGoogle Scholar
  71. 71.
    Wertz IE, O’Rourke KM, Zhang Z et al. Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science 2004; 303:1371–1374.PubMedGoogle Scholar
  72. 72.
    Cope GA, Suh GS, Aravind L et al. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science 2002; 298:608–611.PubMedGoogle Scholar
  73. 73.
    Tran HJ, Allen MD, Lowe J et al. Structure of the Jab1/MPN domain and its implications for proteasome function. Biochemistry 2003; 42:11460–11465.PubMedGoogle Scholar
  74. 74.
    Ambroggio XI, Rees DC, Deshaies RJ. JAMM: A Metalloprotease-Like Zinc Site in the Proteasome and Signalosome. PLoS Biol 2004; 2:E2.PubMedGoogle Scholar
  75. 75.
    Zhou C, Wee S, Rhee E et al. Fission yeast COP9/signalosome suppresses cullin activity through recruitment of the deubiquitylating enzyme Ubp12p. Mol Cell 2003; 11:927–938.PubMedGoogle Scholar
  76. 76.
    Yang X, Menon S, Lykke-Andersen K et al. The COP9 signalosome inhibits p27(kip1) degradation and impedes G1-S phase progression via deneddylation of SCF Cul1. Curr Biol 2002; 12:667–672.PubMedGoogle Scholar
  77. 77.
    Schwechheimer C, Serino G, Callis J et al. Interactions of the COP9 signalosome with the E3 ubiquitin ligase SCFTIRI in mediating auxin response. Science 2001; 292:1379–1382.PubMedGoogle Scholar
  78. 78.
    Pintard L, Kurz T, Glaser S et al. Neddylation and deneddylation of CUL-3 is required to target MEI-1/ Katanin for degradation at the meiosis-to-mitosis transition in C. elegans. Curr Biol 2003; 13:911–921.PubMedGoogle Scholar
  79. 79.
    Doronkin S, Djagaeva I, Beckendorf SK. The COP9 signalosome promotes degradation of Cyclin E during early Drosophila oogenesis. Dev Cell 2003; 4:699–710.PubMedGoogle Scholar
  80. 80.
    Wu JT, Lin HC, Hu YC et al. Neddylation and deneddylation regulate Cul1 and Cul3 protein accumulation. Nat Cell Biol 2005; 7:1014–1020.PubMedGoogle Scholar
  81. 81.
    Wee S, Geyer RK, Toda T et al. CSN facilitates Cullin-RING ubiquitin ligase function by counteracting autocatalytic adapter instability. Nat Cell Biol 2005; 7:387–391.PubMedGoogle Scholar
  82. 82.
    He Q, Cheng P, He Q et al. The COP9 signalosome regulates the Neurospora circadian clock by controlling the stability of the SCFFWD-1 complex. Genes Dev 2005; 19:1518–1531.PubMedGoogle Scholar
  83. 83.
    Cope GA, Deshaies RJ. Targeted silencing of Jab1/Csn5 in human cells downregulates SCF activity through reduction of F-box protein levels. BMC Biochem 2006; 7:1.PubMedGoogle Scholar
  84. 84.
    Wang X, Feng S, Nakayama N et al. The COP9 signalosome interacts with SCF UFO and participates in Arabidopsis flower development. Plant Cell 2003; 15:1071–1082.PubMedGoogle Scholar
  85. 85.
    Wolf DA, Zhou C, Wee S. The COP9 signalosome: an assembly and maintenance platform for cullin ubiquitin ligases? Nat Cell Biol 2003; 5:1029–1033.PubMedGoogle Scholar
  86. 86.
    Emberley ED, Alowami S, Snell L et al. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast. Breast Cancer Res 2004; 6:R308–R315.PubMedGoogle Scholar
  87. 87.
    Sui L, Dong Y, Ohno M et al. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Clin Cancer Res 2001; 7:4130–4135.PubMedGoogle Scholar
  88. 88.
    Rassidakis GZ, Claret FX, Lai R et al. Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma. Clin Cancer Res 2003; 9:1121–1128.PubMedGoogle Scholar
  89. 89.
    Adler AS, Lin M, Horlings H et al. Genetic regulators of large-scale transcriptional signatures in cancer. Nat Genet 2006; 38:421–430.PubMedGoogle Scholar
  90. 90.
    Chang HY, Sneddon JB, Alizadeh AA et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2004; 2:E7.PubMedGoogle Scholar
  91. 91.
    Adler AS, Littlepage LE, Lin M et al. CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression. Cancer Res 2008; 68:506–515.PubMedGoogle Scholar
  92. 92.
    Welcker M, Orian A, Jin J et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA 2004; 101:9085–9090.PubMedGoogle Scholar
  93. 93.
    Yada M, Hatakeyama S, Kamura T et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 2004; 23:2116–2125.PubMedGoogle Scholar
  94. 94.
    Yan T, Wunder JS, Gokgoz N et al. COPS3 amplification and clinical outcome in osteosarcoma. Cancer 2007; 109:1870–1876.PubMedGoogle Scholar
  95. 95.
    Luo J, Emanuele MJ, Li D et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 2009; 137:835–848.PubMedGoogle Scholar
  96. 96.
    Groisman R, Polanowska J, Kuraoka I et al. The ubiquitin ligase activity in the DD B2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 2003; 113:357–367.PubMedGoogle Scholar
  97. 97.
    Xirodimas DP, Saville MK, Bourdon JC et al. Mdm2-mediated NED 8 conjugation of p53 inhibits its transcriptional activity. Cell 2004; 118:83–97.PubMedGoogle Scholar
  98. 98.
    Stickle NH, Chung J, Klco JM et al. pVHL modification by NED 8 is required for fibronectin matrix assembly and suppression of tumor development. Mol Cell Biol 2004; 24:3251–3261.PubMedGoogle Scholar
  99. 99.
    Xirodimas DP, Sundqvist A, Nakamura A et al. Ribosomal proteins are targets for the NED 8 pathway. EMBO Rep 2008; 9:280–286.PubMedGoogle Scholar
  100. 100.
    Rabut G, Peter M. Function and regulation of protein neddylation. ‘Protein modifications: beyond the usual suspects’ review series. EMBO Rep 2008; 9:969–976.PubMedGoogle Scholar
  101. 101.
    Chan Y, Yoon J, Wu JT et al. DE N1 deneddylates noncullin proteins in vivo. J Cell Sci 2008; 121:3218–3223.PubMedGoogle Scholar
  102. 102.
    Zhou L, Watts FZ. Nep1, a Schizosaccharomyces pombe deneddylating enzyme. Biochem J 2005; 389:307–314.PubMedGoogle Scholar
  103. 103.
    Norman JA, Shiekhattar R. Analysis of Nedd8-associated polypeptides: a model for deciphering the pathway for ubiquitin-like modifications. Biochemistry 2006; 45:3014–3019.PubMedGoogle Scholar
  104. 104.
    Li T, Santockyte R, Shen RF et al. A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers. Arch Biochem Biophys 2006; 453:70–74.PubMedGoogle Scholar
  105. 105.
    Deshaies RJ. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu Rev Cell Dev Biol 1999; 15:435–467.PubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2010

Authors and Affiliations

  • Raymond J. Deshaies
    • 1
  • Ethan D. Emberley
    • 1
  • Anjanabha Saha
    • 1
    • 2
  1. 1.Division of Biology, Howard Hughes Medical InstituteCalifornia Institute of TechnologyPasadenaUSA
  2. 2.Oncology, Cancer ResearchGlaxoSmithKlineCollegevilleUSA

Personalised recommendations